Dr. Candice Ruby, MD

NPI: 1407904451
Total Payments
$3,542
2024 Payments
$3,423
Companies
5
Transactions
9

Payment Breakdown by Category

Consulting$3,300 (93.2%)
Food & Beverage$141.92 (4.0%)
Education$99.95 (2.8%)

Payments by Nature

Nature of Payment Amount Transactions Share
Consulting Fee $3,300 6 93.2%
Food and Beverage $141.92 2 4.0%
Education $99.95 1 2.8%

Top Paying Companies

Company Total Records Latest Year
AstraZeneca Pharmaceuticals LP $2,625 5 $0 (2024)
BeiGene USA, Inc. $675.00 1 $0 (2024)
Exelixis Inc. $122.99 1 $0 (2024)
SANOFI-AVENTIS U.S. LLC $99.95 1 $0 (2018)
Kite Pharma, Inc. $18.93 1 $0 (2019)

Payment History by Year

Year Amount Transactions Top Company
2024 $3,423 7 AstraZeneca Pharmaceuticals LP ($2,625)
2019 $18.93 1 Kite Pharma, Inc. ($18.93)
2018 $99.95 1 SANOFI-AVENTIS U.S. LLC ($99.95)

All Payment Transactions

9 individual payment records from CMS Open Payments

Date Company Product Nature Form Amount Type
12/12/2024 AstraZeneca Pharmaceuticals LP Truqap (Drug) Consulting Fee Cash or cash equivalent $525.00 General
Category: Oncology
11/26/2024 BeiGene USA, Inc. BRUKINSA (Drug) Consulting Fee Cash or cash equivalent $675.00 General
Category: Oncology
11/12/2024 Exelixis Inc. CABOMETYX (Drug) Food and Beverage In-kind items and services $122.99 General
Category: Renal Cell Carcinoma (RCC) Hepatocellular Carcinoma (HCC) Differentiated Thyroid Cancer (DTC)
10/30/2024 AstraZeneca Pharmaceuticals LP IMFINZI (Biological) Consulting Fee Cash or cash equivalent $525.00 General
Category: Oncology
10/30/2024 AstraZeneca Pharmaceuticals LP IMFINZI (Biological) Consulting Fee Cash or cash equivalent $525.00 General
Category: Oncology
10/01/2024 AstraZeneca Pharmaceuticals LP IMFINZI (Biological) Consulting Fee Cash or cash equivalent $525.00 General
Category: Oncology
05/22/2024 AstraZeneca Pharmaceuticals LP IMFINZI (Biological) Consulting Fee Cash or cash equivalent $525.00 General
Category: Oncology
12/18/2019 Kite Pharma, Inc. Yescarta (Drug) Food and Beverage In-kind items and services $18.93 General
Category: ONC
06/08/2018 SANOFI-AVENTIS U.S. LLC JEVTANA (Drug) Education In-kind items and services $99.95 General
Category: ONCOLOGY

About Dr. Candice Ruby, MD

Dr. Candice Ruby, MD is a Hematology & Oncology healthcare provider based in Riverside, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/08/2007. The National Provider Identifier (NPI) number assigned to this provider is 1407904451.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Candice Ruby, MD has received a total of $3,542 in payments from pharmaceutical and medical device companies, with $3,423 received in 2024. These payments were reported across 9 transactions from 5 companies. The most common payment nature is "Consulting Fee" ($3,300).

Practice Information

  • Specialty Hematology & Oncology
  • Location Riverside, CA
  • Active Since 01/08/2007
  • Last Updated 11/22/2021
  • Taxonomy Code 207RH0003X
  • Entity Type Individual
  • NPI Number 1407904451

Products in Payments

  • IMFINZI (Biological) $2,100
  • BRUKINSA (Drug) $675.00
  • Truqap (Drug) $525.00
  • CABOMETYX (Drug) $122.99
  • JEVTANA (Drug) $99.95
  • Yescarta (Drug) $18.93

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Hematology & Oncology Doctors in Riverside